Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Am J Med. 2018 Sep 19;132(1):71–80.e1. doi: 10.1016/j.amjmed.2018.09.011

Figure 4.

Figure 4.

Subgroup analyses for the combined endpoint by discharge prescription for spironolactone in 1724 propensity score-matched patients with heart failure, left ventricular ejection fraction ≤35%, no prior spironolactone therapy, and serum creatinine ≤2.5mg/dL for men and ≤2.0mg/dL for women